PREDICTION OF POST-TRANSPLANT RELAPSE IN THE MYELODYSPLASTIC SYNDROMES VIA EVALUATION OF STEM CELLS

PREDICTION OF POST-TRANSPLANT RELAPSE IN THE MYELODYSPLASTIC SYNDROMES VIA EVALUATION OF STEM CELLS

Introduction: Allogeneic stem cell transplant (alloSCT) remains the only curative treatment for the myelodysplastic syndromes (MDS), but relapse is common. Studies using error-corrected sequencing (ECS) on bulk bone marrow (BM) have shown that molecular residual disease is predictive of relapse. But...

Full description

Bibliographic Details
Main Authors: S. Chung, B. Kroger, Y. Huang, A. Son, P. Carlsgaard, L. Pop, R. Vittrup, F. Kalkan, A. Cherukuri, D. Sallman, R. Tamari, C. Gurnari, J. Maciejewski, Y. Madanat
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Leukemia Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048924000244

Internet

http://www.sciencedirect.com/science/article/pii/S2213048924000244

Similar Items